Currently predicting for Thu, 4 Jun 2026

ABBV Prediction Chart

ABBV Predictions History

Latest community submissions for ABBV.
Predictor Target Session Target Price Result Direction Accuracy Score
Apr 30, 2019 $80.19 +1.01% $79.39 X 98.99% 1
Chaser Chaser Pro
Apr 30, 2019 $79.80 +0.52% $79.39 X 99.48% 3
Apr 29, 2019 $78.92 -1.72% $80.30 X 98.28% 0
Apr 23, 2019 $78.82 +0.20% $78.66 X 99.80% 5
Apr 22, 2019 $77.78 -0.47% $78.15 X 99.53% 4
Chaser Chaser Pro
Mar 22, 2019 $83.87 +5.15% $79.76 X 94.80% 0
Chaser Chaser Pro
Mar 13, 2019 $79.33 +0.51% $78.93 X 99.50% 3
so so @so.85197
Aug 7, 2018 $88.99 -5.39% $94.06 X 94.60% 0
Mar 19, 2018 $116.35 +3.86% $112.03 X 96.10% 0
Luxbu Luxbu @Luxbu.21925
Mar 16, 2018 $122.85 +8.04% $113.71 X 92.00% 0
Click to get the best stock tips daily for free!
Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for ABBV with a full price path, not just a one-day call.
  • Price path
  • Approved predictor
  • 3-month horizon
ABOUT ABBVIE INC
AbbVie
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheumatoid arthritis in adult patients; IMBRUVICA to treat adult patients with chronic lymphocytic leukemia ...
GOLDEN STAR
Ticker Change Signal Date
RUN
$12.83
18.86% May 06
GLBE
$31.61
5.35% May 05
SAP
$172.39
10.69% May 05
W
WCLD
$27.34
27.18% Apr 29
ADBE
$243.57
7.61% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE